____________________________________________________________________________________________ LabLogic Systems
“ Another key specialty of ours is what we call validation services . To operate in highly regulated environments , companies must undergo validation to make sure that their instruments and software are fit for purpose , and we can assist them in getting individual sites up and running through our validation services . Furthermore , we develop new instrumentation and conduct R & D projects . This is particularly relevant in nuclear medicine , where many new technologies and techniques are emerging . We are also working on cancer research and creating new instrumentation to help with cancer diagnosis and treatments ,” he expands .
Cancer research is a key area of focus at LabLogic at the moment . Richard shares insights into the company ’ s work and objectives in the field . “ For the past 15 years , we have been heavily invested in PET , a
specific aspect of nuclear medicine . PET is particularly useful in the detection of cancer , as it provides a full body image . Not only does PET allow oncologists to diagnose the presence of cancer early on ( thereby offering better chances of remissions ), but it also enables them to evaluate the extent of the cancer ’ s spread in the body . Prior to carrying out a PET scan , a radioactive drug ( known as a tracer ) must be injected into the body . The tracer must undergo a variety of quality control ( QC ) checks before it is allowed to be used , and we have developed a significant portion of the hardware and software used in this process .”
Striving to stay ahead of industry research and developments , LabLogic is becoming increasingly involved in an upand-coming medical concept . “ Beyond PET , the next big thing in the field is theranostics ,
manufacturing-today . com 75